Contact this trialFirst, we need to learn more about you.
Peptide
CyPep-1 + Pembrolizumab for Advanced Cancers
Recruiting1 awardPhase 1 & 2
Dallas, Texas
This trial tests a new treatment that injects a special protein and an immune-boosting drug into tumors. It targets patients with advanced or hard-to-treat cancers. The treatment helps the immune system recognize and attack cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.